Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Rifampicin | hsa00220 | Arginine biosynthesis | 3.59E-02 | 2 | P15104, P05089 | GLUL, ARG1 | More | | Rifampicin | hsa00500 | Starch and sucrose metabolism | 1.22E-02 | 3 | O43451, P46976, P06737 | MGAM, GYG1, PYGL | More | | Rifampicin | hsa00533 | Glycosaminoglycan biosynthesis - keratan sulfate | 3.43E-02 | 1 | Q9NY97 | B3GNT2 | More | | Rifampicin | hsa00730 | Thiamine metabolism | 3.59E-02 | 2 | P05186, P24666 | ALPL, ACP1 | More | | Rifampicin | hsa00920 | Sulfur metabolism | 8.89E-03 | 1 | Q16762 | TST | More | | Rifampicin | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 3.10E-02 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | | Rifampicin | hsa00982 | Drug metabolism - cytochrome P450 | 3.10E-02 | 2 | P11712, P78417 | CYP2C9, GSTO1 | More | | Rifampicin | hsa01100 | Metabolic pathways | 2.12E-02 | 23 | P05089, P21953, P15144, P15104, P55809, P06280, Q16875, O43286, O43451, P05186, P24666, Q9HCC0, P33121, Q08477, P15907, Q8N4A0, P57054, Q9UNP4, P37837, Q9BPW9, P43490, P46976, P06737 | ARG1, BCKDHB, ANPEP, GLUL, OXCT1, GLA, PFKFB3, B4GALT5, MGAM, ALPL, ACP1, MCCC2, ACSL1, CYP4F3, ST6GAL1, GALNT4, PIGP, ST3GAL5, TALDO1, DHRS9, PBEF1, GYG1, PYGL | More | | Rifampicin | hsa03010 | Ribosome | 1.88E-02 | 6 | P62753, P25398, P32969, P62829, P18077, P36578 | RPS6, RPS12, RPL9, RPL23, RPL35A, RPL4 | More | | Rifampicin | hsa03020 | RNA polymerase | 3.59E-02 | 2 | P30876, P62487 | POLR2B, POLR2G | More | | Rifampicin | hsa03040 | Spliceosome | 1.27E-02 | 6 | O43143, P08579, Q13595, Q07955, P84103, P11142 | DHX15, SNRPB2, TRA2A, SFRS1, SFRS3, HSPA8 | More | | Rifampicin | hsa04014 | Ras signaling pathway | 4.12E-02 | 5 | P20827, P49767, Q14644, P0DP23, P63218 | EFNA1, VEGFC, RASA3, CALM1, GNG5 | More | | Rifampicin | hsa04020 | Calcium signaling pathway | 3.36E-03 | 6 | Q16566, P30679, O15399, P0DP23, P23634, P49767 | CAMK4, GNA15, GRIN2D, CALM1, ATP2B4, VEGFC | More | | Rifampicin | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 4.48E-02 | 5 | P25024, P25025, P47992, Q9UBD3, P01375 | CXCR1, CXCR2, XCL1, XCL2, TNF | More | | Rifampicin | hsa04122 | Sulfur relay system | 8.89E-03 | 1 | Q16762 | TST | More | | Rifampicin | hsa04141 | Protein processing in endoplasmic reticulum | 4.88E-02 | 4 | P18848, O60337, P11142, P07900 | ATF4, MARH6, HSPA8, HSP90AA1 | More | | Rifampicin | hsa04215 | Apoptosis - multiple species | 1.56E-02 | 2 | Q13489, P10415 | BIRC3, BCL2 | More | | Rifampicin | hsa04217 | Necroptosis | 4.42E-04 | 6 | P07900, P15104, P05141, P01584, P0C0S5, Q13557 | HSP90AA1, GLUL, SLC25A5, IL1B, H2AFZ, CAMK2D | More | | Rifampicin | hsa04371 | Apelin signaling pathway | 4.16E-02 | 4 | P63218, Q13485, Q16566, P0DP23 | GNG5, SMAD4, CAMK4, CALM1 | More | | Rifampicin | hsa04380 | Osteoclast differentiation | 8.20E-03 | 7 | Q9UQC2, Q16539, P14778, O75015, P01375, Q8N149, P78324 | GAB2, MAPK14, IL1R1, FCGR3B, TNF, LILRA2, SIRPA | More | | Rifampicin | hsa04390 | Hippo signaling pathway | 2.08E-02 | 3 | P84022, Q13485, Q13489 | SMAD3, SMAD4, BIRC3 | More | | Rifampicin | hsa04610 | Complement and coagulation cascades | 4.48E-02 | 3 | P01042, P09871, P11215 | KNG1, C1S, ITGAM | More | | Rifampicin | hsa04614 | Renin-angiotensin system | 3.52E-02 | 1 | P10619 | CTSA | More | | Rifampicin | hsa04650 | Natural killer cell mediated cytotoxicity | 3.82E-02 | 6 | P01375, P78314, O60880, P20963, P26718, O75015 | TNF, SH3BP2, SH2D1A, CD247, KLRK1, FCGR3B | More | | Rifampicin | hsa04657 | IL-17 signaling pathway | 3.03E-03 | 7 | P07900, O00463, Q16539, P49841, P14780, P01375, P01584 | HSP90AA1, TRAF5, MAPK14, GSK3B, MMP9, TNF, IL1B | More | | Rifampicin | hsa04659 | Th17 cell differentiation | 3.17E-02 | 3 | P25963, P84022, Q13485 | NFKBIA, SMAD3, SMAD4 | More | | Rifampicin | hsa04660 | T cell receptor signaling pathway | 4.63E-02 | 6 | P01375, P07766, P20963, Q13191, Q16539, P49841 | TNF, CD3E, CD247, CBLB, MAPK14, GSK3B | More | | Rifampicin | hsa04710 | Circadian rhythm | 1.67E-02 | 2 | Q16526, Q9Y478 | CRY1, PRKAB1 | More | | Rifampicin | hsa04720 | Long-term potentiation | 1.79E-02 | 3 | Q16566, P0DP23, O15399 | CAMK4, CALM1, GRIN2D | More | | Rifampicin | hsa04724 | Glutamatergic synapse | 4.48E-02 | 3 | O15399, P63218, Q9NSB8 | GRIN2D, GNG5, HOMER2 | More | | Rifampicin | hsa04920 | Adipocytokine signaling pathway | 4.31E-02 | 2 | Q9Y478, Q96RR4 | PRKAB1, CAMKK2 | More | | Rifampicin | hsa04924 | Renin secretion | 4.38E-02 | 1 | P07550 | ADRB2 | More | | Rifampicin | hsa04925 | Aldosterone synthesis and secretion | 3.44E-02 | 3 | P0DP23, Q16566, P23634 | CALM1, CAMK4, ATP2B4 | More | | Rifampicin | hsa04932 | Non-alcoholic fatty liver disease | 9.70E-03 | 4 | P18848, P01584, P13073, O15239 | ATF4, IL1B, COX4I1, NDUFA1 | More | | Rifampicin | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 1.25E-02 | 3 | P84022, Q13485, P10415 | SMAD3, SMAD4, BCL2 | More | | Rifampicin | hsa04975 | Fat digestion and absorption | 3.43E-02 | 1 | O14494 | PLPP1 | More | | Rifampicin | hsa05012 | Parkinson disease | 2.53E-02 | 5 | O15239, P13073, P05141, P18848, Q13557 | NDUFA1, COX4I1, SLC25A5, ATF4, CAMK2D | More | | Rifampicin | hsa05016 | Huntington disease | 3.21E-02 | 5 | O15239, P13073, P30876, P62487, P05141 | NDUFA1, COX4I1, POLR2B, POLR2G, SLC25A5 | More | | Rifampicin | hsa05020 | Prion disease | 3.37E-03 | 7 | P13591, P01584, P11142, O15239, P13073, P18848, P05141 | NCAM1, IL1B, HSPA8, NDUFA1, COX4I1, ATF4, SLC25A5 | More | | Rifampicin | hsa05022 | Pathways of neurodegeneration - multiple diseases | 3.80E-02 | 6 | O15239, P13073, P18848, P05141, P01584, Q13557 | NDUFA1, COX4I1, ATF4, SLC25A5, IL1B, CAMK2D | More | | Rifampicin | hsa05034 | Alcoholism | 1.05E-02 | 6 | O15399, Q16566, P0DP23, P63218, O60814, P68431 | GRIN2D, CAMK4, CALM1, GNG5, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Rifampicin | hsa05132 | Salmonella infection | 2.04E-02 | 4 | P25963, Q13489, P10415, Q9BQS8 | NFKBIA, BIRC3, BCL2, FYCO1 | More | | Rifampicin | hsa05133 | Pertussis | 1.70E-03 | 4 | P11215, P0DP23, P23528, P09871 | ITGAM, CALM1, CFL1, C1S | More | | Rifampicin | hsa05134 | Legionellosis | 1.28E-02 | 3 | P01584, P68104, P11142 | IL1B, EEF1A1, HSPA8 | More | | Rifampicin | hsa05145 | Toxoplasmosis | 2.78E-02 | 3 | P25963, P10415, Q13489 | NFKBIA, BCL2, BIRC3 | More | | Rifampicin | hsa05161 | Hepatitis B | 8.49E-03 | 4 | P25963, Q13485, P10415, P84022 | NFKBIA, SMAD4, BCL2, SMAD3 | More | | Rifampicin | hsa05162 | Measles | 4.02E-02 | 3 | P11142, P01584, Q9NP90 | HSPA8, IL1B, RAB9B | More | | Rifampicin | hsa05171 | Coronavirus disease - COVID-19 | 9.72E-03 | 7 | P01584, P62753, P25398, P36578, P32969, P18077, P62829 | IL1B, RPS6, RPS12, RPL4, RPL9, RPL35A, RPL23 | More | | Rifampicin | hsa05204 | Chemical carcinogenesis | 4.92E-02 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | | Rifampicin | hsa05210 | Colorectal cancer | 1.78E-02 | 3 | P84022, Q13485, P10415 | SMAD3, SMAD4, BCL2 | More | | Rifampicin | hsa05212 | Pancreatic cancer | 3.52E-02 | 2 | P84022, Q13485 | SMAD3, SMAD4 | More | | Rifampicin | hsa05220 | Chronic myeloid leukemia | 1.25E-02 | 3 | Q13485, P25963, P84022 | SMAD4, NFKBIA, SMAD3 | More | | Rifampicin | hsa05222 | Small cell lung cancer | 1.50E-02 | 3 | Q13489, P10415, P25963 | BIRC3, BCL2, NFKBIA | More | | Rifampicin | hsa05226 | Gastric cancer | 2.78E-02 | 3 | P84022, Q13485, P10415 | SMAD3, SMAD4, BCL2 | More | | Rifampicin | hsa05415 | Diabetic cardiomyopathy | 2.87E-02 | 4 | P05141, O15239, P13073, Q13557 | SLC25A5, NDUFA1, COX4I1, CAMK2D | More | | Rifampicin | hsa05418 | Fluid shear stress and atherosclerosis | 1.95E-02 | 6 | Q16539, P10599, P14780, P01375, P14778, P27930 | MAPK14, TXN, MMP9, TNF, IL1R1, IL1R2 | More | | |